William A. Haseltine, Contributor

Author's posts

What Are Viroids? Taking A Peek At The World’s Smallest Pathogens

Small but mighty, viroids are disease-causing infectious strands of RNA that can self replicate. Unlike viruses, they don’t possess any proteins of their own.

Hepatitis C, The Disease, Epidemiology, Treatment, Eradication Part 1: The Disease

First in a series, here we explain what hepatitis C is and how it affects the body, as well as explore the barriers to curing hepatitis and propose new strategies to eliminate the disease.

CAR T Cell-Like Therapy To Treat T Cell Leukemia (T-ALL)

Here we discuss a study published in the journal BMJ investigates a promising new approach inspired by CAR T therapy on mouse models.

Can Intermittent Fasting Help You Live Longer?

Intermittent fasting is unique to other forms of dieting because you do not necessarily have to change what you eat to see results. Now, a recent study from the University of Utah hints that it may also help you to live longer.

Lab-Grown Red Blood Cells May Soon Be Available For Safe Transfusions

The National Health Service recently launched a world-first clinical trial that tests the safety of transfusing lab-grown blood cells into patients.

Inherited Differences In Antibody Genes May Explain Variable Responses To Covid-19 Infection

Genetic differences from person to person may influence the antibodies they develop to SARS-CoV-2 and other pathogens.

Will Nasal Vaccines Lift Us Out Of The Pandemic?

Nasal IgA antibodies may help prevent SARS-CoV-2 infection. Unfortunately, our current vaccines fail to boost IgA. Can nasal vaccines provide a way forward?

Robotics Offer New Hope For Recovery From Traumatic Spinal Injuries

Scientists have developed a robotic prosthetic that offers new hope of recovery for patients suffering from traumatic spinal injuries.

Artificial Intelligence Opens The Door To More Effective Antibodies – Potential Applications For Covid-19

Advances in artificial intelligence antibody modeling may pave the way for more efficient antibody drug discovery in the near future.

Taking A Closer Look At Molnupiravir. Is Continued Use Justified?

Research suggests molnupiravir may supercharge new SARS-CoV-2 variants.